Weight loss pill could arrive by Christmas | 7NEWS

Danish pharmaceutical company Novo Nordisk is seeking regulatory approval from the TGA for a pill version of the weight loss injection Wegovy, with a decision expected by Christmas. The once-a-day oral medication contains semaglutide, a GLP-1 peptide that suppresses appetite, and would be the first approved oral GLP-1 peptide for chronic weight management in Australia. With two in three Australian adults and one in four school-aged children now overweight or obese, doctors emphasise the need for more treatment options to intervene early and prevent weight-related health conditions.

Subscribe and set 🔔 » https://7news.link/YTSubscribe |

For the latest Australian news and breaking news alerts, connect with 7NEWS online:
Visit » https://7news.com.au
7Plus » https://7plus.com.au/
7NEWS Podcast » https://open.spotify.com/user/dm9fk9hzoe68ibpttheragdgi
Facebook » https://www.facebook.com/7NewsAustralia
TikTok » https://www.tiktok.com/@7newsaustralia
Instagram » https://www.instagram.com/7newsaustralia/
X » https://x.com/7NewsAustralia

7NEWS combines the trusted and powerful news brands including Sunrise, The Morning Show, Spotlight and 7NEWS.com.au, delivering unique, engaging and continuous coverage on the issues that matter most to Australians. Watch 7 News Australia full broadcasts and full episodes at 6pm and weekdays at 12pm and 4pm on Channel 7 and 7plus.

#BREAKINGNEWS #7NEWS

Share on: